Danvers, MA 7/9/09—Cell Signaling Technology (CST), a manufacturer of antibodies and reagent products, has acquired all the shares of Netherlands-based BIOKÉ BV, its distributor for the Benelux region. Renamed Cell Signaling Technology Europe, the business will begin filling orders effective January 1, 2010. “This acquisition will permit CST to better support its European customers and distributors and help increase the company’s brand recognition in that region of the world,” stated Fenel M. Eloi, COO of CST. “A company needs to have good control of its distribution channels in key markets. To that end, CST established its Japanese operation in 2008 followed by China earlier this year and for now concludes with this acquisition in Europe.”